ReviewLung Cancer (Auckland, N.Z.)2010

Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer.

Caroline Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.